Steven O’Day: BOT+BAL Offers New Hope for MSS Colon Cancer
MSS colon cancer remains one of the most challenging areas in immuno-oncology, with limited benefit from conventional checkpoint inhibitors. Agenus is aiming to address this unmet need through…
Read the full article2d agoen
You might also wanna read
Sam Neill’s Cause of Death Was Pneumonia, Actor’s Agent Confirms
NYT·16h ago
Pat Soon-Shiong: Addressing the Global Cancer Pandemic with Immunotherapy and Cell Therapy
OncoDaily·5d ago
Fox Chase Cancer Center Congratulates Parth Desai on ASCO Career Development Award
OncoDaily·8d ago
Naveni® Plex Omni Service – The Future of Spatial Interactomics
resources.biomol.com·8mo ago
Drug for childhood leukemia shows positive results
upstate.edu·11mo ago
Are AI Data Centers Causing Cancer?
SGT Report·48m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.